Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID
Description
CONCLUSIONS: These findings suggest that complement biomarkers could facilitate the diagnosis of long COVID and further suggest that currently available inhibitors of complement activation could be used to treat long COVID.
